Compound Detail
CHEMBL659
GALANTAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL659 |
| Name | GALANTAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ASUTZQLVASHGKV-JDFRZJQESA-N |
| Therapeutic | ✓ Yes |
14
Targets
329
Activities
3
Assay Types
12
PK Parameters
20
Publications
18
Known Names
17
Indications
Molecular Properties
287.4
MW (Da)
1.85
ALogP
4
HBA
1
HBD
41.9
PSA (Ų)
0.80
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2001 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Dementia Alzheimer Disease Anxiety Autistic Disorder Dementia, Vascular Depressive Disorder Lewy Body Disease Schizophrenia Cocaine-Related Disorders HIV Infections Psychotic Disorders Tobacco Use Disorder Hypotension, Orthostatic Lecithin Cholesterol Acyltransferase Deficiency Memory Obesity Subarachnoid Hemorrhage
ATC Classification
N06DA04
galantamine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 305 meas. best 7.29
Ki 20 meas. best 7.21
EC50 4 meas. best 5.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cholinesterase CHEMBL1914 | IC50 | 7.29 | 4.9784 | 51.0 | 49 |
| Acetylcholinesterase CHEMBL220 | Ki | 7.21 | 6.685 | 61.9 | 6 |
| Acetylcholinesterase CHEMBL220 | IC50 | 7.0 | 5.8589 | 100.0 | 80 |
| Acetylcholinesterase CHEMBL4078 | IC50 | 6.88 | 5.8428 | 132.0 | 82 |
| Cholinesterase CHEMBL1914 | Ki | 6.72 | 5.4533 | 192.5 | 6 |
| Acetylcholinesterase CHEMBL4780 | IC50 | 6.44 | 6.28 | 360.0 | 4 |
| Acetylcholinesterase CHEMBL4078 | Ki | 6.37 | 6.055 | 428.0 | 6 |
| Acetylcholinesterase CHEMBL3199 | IC50 | 6.27 | 5.9857 | 538.0 | 7 |
| SH-SY5Y CHEMBL614910 | IC50 | 6.13 | 6.13 | 747.0 | 1 |
| Acetylcholinesterase CHEMBL220 | EC50 | 5.96 | 5.96 | 1100.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 5.83 | 5.6967 | 1480.0 | 3 |
| Acetylcholinesterase CHEMBL3198 | IC50 | 5.68 | 5.64 | 2080.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 5.51 | 5.0933 | 3120.0 | 3 |
| Cholinesterase CHEMBL5763 | IC50 | 5.5 | 4.8695 | 3200.0 | 57 |
| Butyrylcholinesterase CHEMBL3403 | IC50 | 5.23 | 5.23 | 5900.0 | 1 |
| NIH3T3 CHEMBL614822 | IC50 | 5.14 | 5.14 | 7280.0 | 1 |
| Cholinesterase CHEMBL5763 | Ki | 5.11 | 5.11 | 7700.0 | 1 |
| Butyrylcholinesterase CHEMBL5077 | Ki | 5.1 | 5.1 | 8000.0 | 1 |
| Butyrylcholinesterase CHEMBL5077 | IC50 | 5.08 | 4.9611 | 8394.6 | 9 |
| Acetylcholinesterase CHEMBL4768 | IC50 | 5.06 | 5.06 | 8700.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 5.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.6 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.82 | - | Homo sapiens |
| Fu | 0.83 | - | Homo sapiens |
| KA | - | - | Homo sapiens |
| KA | - | - | Homo sapiens |
| KA | - | - | Homo sapiens |
| KA | - | - | Homo sapiens |
| KA | - | - | Homo sapiens |
| Ke | 25.7 | uM | Homo sapiens |
| MRT | 6.8 | hr | Homo sapiens |
| T1/2 | 5.3 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine